Migraine

The FDA has approved Pfizer’s Zavzpret, a calcitonin gene-related peptide receptor antagonist nasal spray to treat migraine with or without aura in adults.

Vistagen announced that the U.S. Patent and Trademark Office granted a patent for the company’s investigational pherine PH80 nasal spray for the treatment of migraine.

The central retinal artery is one of the main arterial supplies for the retina. It pierces the eyeball close to the optic nerve and within the dural sheath, and it branches and supplies the inner retinal layers.

Healio and Cardiology Today have compiled a list of the most read cardiology news of January 2022.

Despite the number of new medications produced to treat a range of neurologic diseases, limited utilization is driven by relatively high cost and similar efficacy to less expensive drugs, according to a study published in Neurology.

U.S. adults who reported a history of migraine or severe headache were 25% more likely to develop hypertension compared with those with no migraine history, with a higher risk for women vs. men, researchers reported.

Migraine has a bidirectional relationship with mental disorders such as anxiety and depression, and one may increase the risk of the other, researchers reported in Cureus.

With an estimated 1 billion people affected by migraine worldwide, there is an urgent need to provide effective treatment for this debilitating disease.

CHICAGO — COVID-19-induced hyposmia eliminated odor-induced migraine headaches in an older adult, a case study presented at the 2022 American Neurological Association’s annual meeting showed.

CHICAGO — With more than 1.5 million veterans diagnosed with headache over the past two decades, the Veterans Health Administration must improve outreach and care to address disparities, an expert said at ANA 2022.